Skip to the page

Data / Form D filings / ALLIEDPATH, INC

ALLIEDPATH, INC: Form D filings

ALLIEDPATH, INC, a biotechnology company in San Diego, CA, filed 2 Form D notices with the SEC in 2010. The latest, on May 20, 2010, reports $150,000 sold of a $450,000 offering to 1 investor.

Find out what ALLIEDPATH, INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
10455 PACIFIC CENTER COURT, San Diego, CA, 92121
Phone
(858) 768-5360
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2008
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506
SEC identifier (CIK)
1449759

The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 20, 2010New notice$450,000$150,000$300,0001May 5, 2010sec.gov
May 20, 2010New notice$490,000$490,000$02Oct 27, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Roberta L. Della VedovaExecutive Officer, Director
Bruce A. HuebnerDirector
Heiner A. Dreismann, Ph.D.Director
Philip J. Ginsburg, M.D.Executive Officer, Director

Other biotechnology companies in California that filed recently

Every Form D from the week of May 17, 2010 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what ALLIEDPATH, INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.